Zota Health Care Limited has reported a robust financial performance for FY25, achieving a total revenue of ₹29,297.28 lakhs. The company disclosed this figure in an investor presentation shared with the National Stock Exchange of India on November 6, 2025. This marked a significant milestone for Zota, reflecting its strong positioning within the Indian healthcare sector since its inception in 2000. The company operates a widespread network of over 2,000 SKUs through its Davaindia retail pharmacy chain, which has expanded significantly since its launch in October 2017.

In addition to its domestic success, Zota Health Care has made strides in the export market, servicing 30+ countries and manufacturing over 250 formulations for international markets. The company has received 325 product approvals out of a total of 586 dossier applications, underscoring its commitment to quality and compliance. Furthermore, Zota's strategic investments in Everyday Herbal Beauty Care Private Limited bolster its supply chain and enhance the development of its product portfolio in the over-the-counter (OTC) category, representing their diversification efforts within the healthcare sector.

With a strong operational framework, Zota Health Care currently boasts 2,055 Davaindia stores across India, supported by 1,050 distributors. The company has established itself as a key player in the market with a focus on providing affordable healthcare solutions. As noted in the presentation, stakeholders are encouraged to review the detailed financial results available on Zota's website and the NSE for a comprehensive understanding of the company's performance. The outlook remains positive, with Zota committed to navigating potential challenges in the healthcare landscape while continuing to expand its market presence.